Stallion India Fluorochemicals Posts 79% PAT Growth in Q1 FY27

CHEMICALS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Stallion India Fluorochemicals Posts 79% PAT Growth in Q1 FY27

Stallion India Fluorochemicals reported strong Q1 FY27 results with a 79.15% rise in net profit. The company is preparing to launch its helium plant and is progressing on other expansion projects, though some timelines have shifted.

Stallion India Fluorochemicals Ltd. Q1 FY27 Results

Total Revenue: Rs 124.68 crore (12.78% YoY)
PAT: Rs 18.57 crore (79.15% YoY)

Reader Takeaway: Strong earnings driven by efficient planning; watch margin sustainability and equity dilution plans.

What just happened

Stallion India Fluorochemicals Ltd. announced its financial results for the first quarter of FY27. The company reported a significant 79.15% year-on-year increase in Profit After Tax (PAT) to Rs 18.57 crore. Total revenue grew by 12.78% to Rs 124.68 crore, and EBITDA surged by 75.85% to Rs 25.27 crore.

Why this matters

The robust profit growth indicates improved operational efficiency and a better product mix. The upcoming operationalization of new facilities, particularly the helium plant, is expected to drive future revenue and capacity expansion, aligning with the company's long-term growth targets.

The backstory

Stallion India Fluorochemicals is involved in the manufacturing of fluorochemicals. The company has been focused on expanding its production capacities and diversifying its product portfolio to capture growth opportunities in specialty gases and refrigerants.

What changes now

The company is on the verge of commissioning its high-purity helium processing plant in Khalapur, with commercial operations expected next quarter. Work continues on the R32 facility in Bhilwara and a new facility in Mambattu, Andhra Pradesh. Management reiterated its revenue growth guidance of 30-35% CAGR over the next three years.

Risks to watch

Management has cautioned that the high margins seen in Q1 FY27 may not be sustainable. Additionally, the company is now evaluating the possibility of future equity dilution as part of its fundraising strategy to accelerate growth, which could impact existing shareholders. Some project timelines, like the R32 facility, have also seen delays.

Peer comparison

(Information not available in the filing)

Context metrics (time-bound)

  • The helium plant in Khalapur has an installed capacity of 1,200 metric tons per annum.
  • The R32 facility in Bhilwara has a target capacity of 10,000 metric tons and is now expected to complete by December 2026.
  • The Mambattu facility is expected to be operational by the end of 2024.

What to track next

Investors will be closely watching the commencement of commercial operations at the helium plant, the progress of the R32 and Mambattu facilities, and the company's final decisions on fundraising strategies, particularly concerning potential equity dilution.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.